Lineage Infidelity of MDA-MB-435 Cells

The origin of cell lines is critical in defining cell type-specific biological functions. Several reports (D. T. Ross et al., Nat Genet 2000;24:227–35; G. Ellison et al., J Clin Pathol Mol Pathol 2002;55:294–9) suggested that the MDA-MB-435 cell line, a cell line extensively used for studying breast cancer biology, has a gene expression pattern most compatible with melanocyte origin. However, we demonstrate that MDA-MB-435 cells express breast-specific or epithelial-specific markers. Also, MDA-MB-435 cells were induced to express breast differentiation-specific proteins and secrete milk lipids as observed in other well-established breast cancer cell lines. Notably, MDA-MB-435 cells also expressed melanocyte-specific proteins as did another highly aggressive breast cancer cell line. MDA-MB-435 xenograft tissue sections stained entirely positive for epithelium-specific markers but only partially positive for melanocyte-specific markers. Thus, MDA-MB-435 is most likely a breast epithelial cell line that has undergone lineage infidelity.

[1]  A. Hamburger,et al.  Regulation of heregulinβ1‐induced differentiation in a human breast carcinoma cell line by the extracellular‐regulated kinase (ERK) pathway , 1998, Journal of cellular biochemistry.

[2]  M. Gonda,et al.  Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1. , 1997, Journal of immunological methods.

[3]  S. Bacus,et al.  Differentiation of cultured human breast cancer cells (AU‐565 and MCF‐7) associated with loss of cell surface HER‐2/neu antigen , 1990, Molecular carcinogenesis.

[4]  J. Bartek,et al.  Production and Characterization of Monoclonal Antibodies to Human Casein. A Monoclonal Antibody That Cross-Reacts With Casein and α-Lactalbumin , 1985 .

[5]  Dihua Yu,et al.  Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. , 1997, Cancer research.

[6]  I. Fidler,et al.  Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. , 1991, Invasion & metastasis.

[7]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[8]  G. Ellison,et al.  Further evidence to support the melanocytic origin of MDA-MB-435 , 2002, Molecular pathology : MP.

[9]  Wolfgang Henrich,et al.  The prognostic significance of epithelial-mesenchymal transition in breast cancer. , 2002, Anticancer research.

[10]  A. Patchefsky,et al.  Primary combined malignant melanoma and ductal carcinoma of the breast: A report of two cases , 1996, Cancer.

[11]  C. Gillett,et al.  A comparative immunohistochemical study of mammary and extramammary Paget's disease and superficial spreading melanoma, with particular emphasis on melanocytic markers , 1996, Virchows Archiv.

[12]  K. Prasad,et al.  Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture. , 1982, Cancer research.

[13]  Jun Yao,et al.  Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. , 1998, Molecular cell.

[14]  P. Chu,et al.  Keratin expression in human tissues and neoplasms , 2002, Histopathology.

[15]  T. Powles,et al.  Prediction of clinical outcome from primary tamoxifen by expression of biologic markers in breast cancer patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  L. Leder,et al.  Lineage infidelity in chronic myeloid leukemia , 1986, Virchows Archiv. B, Cell pathology including molecular pathology.

[17]  N. Ohuchi,et al.  The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. , 2001, International journal of oncology.

[18]  P. Brown,et al.  Role of extracellular signal–regulated kinase pathway in RRR‐α‐tocopheryl succinate–induced differentiation of human MDA‐MB‐435 breast cancer cells , 2002, Molecular carcinogenesis.

[19]  S. Futagawa,et al.  Breast carcinoma diverging to aberrant melanocytic differentiation: a case report with histopathologic and loss of heterozygosity analyses. , 1999, The American journal of surgical pathology.

[20]  Omgo E. Nieweg,et al.  Frozen Section Investigation of the Sentinel Node in Malignant Melanoma and Breast Cancer , 2001, Annals of Surgical Oncology.

[21]  M. Pasdar,et al.  The importance of MUC1 cellular localization in patients with breast carcinoma , 2001, Cancer.

[22]  M. Hendrix,et al.  Molecular biology of breast cancer metastasis Molecular expression of vascular markers by aggressive breast cancer cells , 2000, Breast Cancer Research.

[23]  J. Klostergaard,et al.  Cytotoxic effects of sphingolipids as single or multi-modality agents on human melanoma and soft tissue sarcoma in vitro , 1998, Melanoma research.

[24]  C. Bucana,et al.  Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites. , 1989, Journal of the National Cancer Institute.

[25]  B. Brinkley,et al.  Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro. , 1980, Cancer research.

[26]  J. Lakins,et al.  Expression and regulation of estrogen receptor beta in human breast tumors and cell lines. , 2000, Oncology reports.

[27]  Dihua Yu,et al.  ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma , 2002, Cancer.

[28]  Y. Katagata,et al.  Keratin expression and its significance in five cultured melanoma cell lines derived from primary, recurrent and metastasized melanomas , 1997, FEBS letters.

[29]  M. Hung,et al.  Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis. , 2002, Molecular cell.

[30]  C. Clavel,et al.  Quantitative cell dispersion analysis: New test to measure tumor cell aggressiveness , 2001, International journal of cancer.

[31]  S. Lakhani,et al.  Proliferation and differentiation in the human breast during pregnancy. , 2000, Differentiation; research in biological diversity.

[32]  J. Sloane,et al.  Distribution of epithelial membrane antigen in normal and neoplastic tissues and its value in diagnostic tumor pathology , 1981, Cancer.

[33]  G. V. Vande Woude,et al.  Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[34]  F. Oesch,et al.  Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic‐T‐cell responses: Evidence for immunoselection of antigen‐loss variants in vivo , 1996, International journal of cancer.

[35]  M. Hendrix,et al.  Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[36]  N. Ohuchi,et al.  The loss of E-cadherin, α- and β-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer , 2001 .

[37]  M. Hung,et al.  Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. , 1995, Cancer research.

[38]  Dihua Yu,et al.  Combined trastuzumab and paclitaxel treatment better inhibits ErbB‐2‐mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone , 2003, Cancer.

[39]  M. Lotem,et al.  Expression of tyrosinase, MIA and MART‐1 in sentinel lymph nodes of patients with malignant melanoma , 2002, The British journal of dermatology.

[40]  W. Yu,et al.  RRR-alpha-tocopheryl succinate induces MDA-MB-435 and MCF-7 human breast cancer cells to undergo differentiation. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[41]  D. Fisher,et al.  Age-resolving Osteopetrosis: A Rat Model Implicating Microphthalmia and the Related Transcription Factor TFE3 , 1998, The Journal of experimental medicine.

[42]  I. Schmidt-Wolf,et al.  Coexpression of lymphoid and myeloid markers on cell surfaces. , 1997, Leukemia & lymphoma.

[43]  D. Taverna,et al.  NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells. , 1995, Oncogene.

[44]  G. Hortobagyi,et al.  Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells. , 2002, Cancer research.

[45]  E. Scanziani,et al.  Comparative study on the metastatic behavior of human tumors in nude, beige/nude/xid and severe combined immunodeficient mice. , 1993, Invasion & metastasis.